Alzinova (Sweden) Today
| ALZ Stock | SEK 3.82 0.04 1.06% |
Performance0 of 100
| Odds Of DistressLess than 43
|
Alzinova is selling for under 3.82 as of the 27th of November 2024; that is 1.06 percent increase since the beginning of the trading day. The stock's last reported lowest price was 3.74. Alzinova has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Alzinova AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Moving against Alzinova Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Alzinova Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alzinova's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alzinova or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Alzinova AB (ALZ) is traded on Stockholm Exchange in Sweden and employs 3 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 139 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alzinova's market, we take the total number of its shares issued and multiply it by Alzinova's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alzinova AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.42 M outstanding shares.
Alzinova generates negative cash flow from operations
Check Alzinova Probability Of Bankruptcy
Ownership AllocationAlzinova holds a total of 32.42 Million outstanding shares. Alzinova AB shows 19.76 percent of its outstanding shares held by insiders and 0.9 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alzinova Ownership Details
Alzinova AB Risk Profiles
Although Alzinova's alpha and beta are two of the key measurements used to evaluate Alzinova's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.63 | |||
| Standard Deviation | 3.58 | |||
| Variance | 12.8 | |||
| Risk Adjusted Performance | (0.02) |
Alzinova Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alzinova without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Alzinova Corporate Management
Elected by the shareholders, the Alzinova's board of directors comprises two types of representatives: Alzinova inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alzinova. The board's role is to monitor Alzinova's management team and ensure that shareholders' interests are well served. Alzinova's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alzinova's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Sandberg | Chief Officer | Profile | |
| Kristina Torfgard | Chief Officer | Profile | |
| Hakan Skogstrom | Chief Officer | Profile | |
| Anders Bylock | Chief Officer | Profile |
Additional Tools for Alzinova Stock Analysis
When running Alzinova's price analysis, check to measure Alzinova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzinova is operating at the current time. Most of Alzinova's value examination focuses on studying past and present price action to predict the probability of Alzinova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alzinova's price. Additionally, you may evaluate how the addition of Alzinova to your portfolios can decrease your overall portfolio volatility.